Blood Banking and Blood Products Report 2021 – Global Market Trajectory & Analytics, 2012-2019 & 2020-2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Blood Banking and Blood Products – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.

Global Blood Banking and Blood Products Market to Reach $47.7 Billion by 2027

Amid the COVID-19 crisis, the global market for Blood Banking and Blood Products estimated at US$38.9 Billion in the year 2020, is projected to reach a revised size of US$47.7 Billion by 2027, growing at a CAGR of 2.9% over the period 2020-2027.

Blood Components & Plasma Products, one of the segments analyzed in the report, is projected to record 3% CAGR and reach US$38.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Equipment, Blood Tests & Other Consumables segment is readjusted to a revised 2.5% CAGR for the next 7-year period.

The U.S. Market is Estimated at $10.5 Billion, While China is Forecast to Grow at 5.4% CAGR

The Blood Banking and Blood Products market in the U.S. is estimated at US$10.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$9.7 Billion by the year 2027 trailing a CAGR of 5.4% over the analysis period 2020 to 2027.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 0.8% and 2.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 1.4% CAGR.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Influencer Market Insights
• World Market Trajectories
• Impact of Covid-19 and a Looming Global Recession
• Blood Transfusion Worldwide: A Kaleidoscope of Stark Contrasts
• Recent Market Activity
• Safety and Availability: The Core Issues
• Current and Future Analysis
• World Blood Components and Plasma Market Analysis
• Red Blood Cells – A Key Blood Component

2. FOCUS ON SELECT PLAYERS (Total 209 Featured):

• AABB
• Abbott Laboratories
• American Red Cross
• America`s Blood Centers
• Beckman Coulter, Inc.
• Becton, Dickinson and Company
• Beijing Tiantan Biological Products Co., Ltd.
• Bharat Serums and Vaccines Ltd.
• Bio Products Laboratory Ltd.
• bioMerieux SA
• Bio-Rad Laboratories, Inc.
• Biotest AG
• Canadian Blood Services
• Cerus Corporation
• China Biologic Products, Inc.
• CSL Behring LLC
• Fenwal Inc.
• Fresenius Kabi AG
• Grifols S.A.
• Haemonetics Corporation
• Immucor Inc.
• Kawasumi Laboratories, Inc.
• Kedrion S.p.A.
• LFB Group
• MacoPharma SA
• New York Blood Center
• Octapharma AG
• Ortho-Clinical Diagnostics, Inc.
• Shanghai RAAS Blood Products Co., Ltd.
• Shire plc
• Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
• Terumo BCT Inc.

3. MARKET TRENDS & DRIVERS

• Blood Plasma Demand Exceeds Supply: Self-Sufficiency is the New Mantra
• Growing Affinity for Home Care Unlocks Opportunities for Home-based IVIg Therapy
• Higher Plasma Center Numbers Key to Secure Raw Material Supply, Costs Remain A Bottleneck
• Platelet Rich Plasma Therapy Market Scales New Heights
• Evolution in Plasma Collection Technologies – Current Achievements and Way Ahead
• Demand for Plasma Derivatives on the Rise
• Immunoglobulins to See Steady Growth
• Increasing Awareness of PID and CIPD Disorders to Drive IVIg Market
• Indications Addressed by Major Global IVIg Manufacturers
• Growing Affinity for Home Care Unlocks Opportunities for Home-based IVIg Therapy
• New Indications to Drive Demand for Albumin
• Low Awareness Affects Apha1 Market
• Recombinants Lead FVIII Market
• Rising Incidence of Cancer Drives Demand for Apheresis Systems
• PrIME: An Innovative High-Yield Process to Address Supply Dearth
• Present State of Plasma Fractionating Industry
• Plasma Fractionation Industry Concentrated in Developed Countries
• PrIME Tackles the Issue of Currently Unprocessable Plasma
• Industry Grappling with Blood Safety & Availability Issues
• New Infections – A Continuous Threat
• Synthetic Substitutes to Bridge Demand-Supply Gap in Blood
• Autologous Transfusion Gearing up for High Growth
• Out-of-Hospital Transfusions: An Emerging Phenomenon
• Automation Tapping into Blood Market
• Automation in Pre-Transfusion Diagnostics
• Penetration of Automated Equipment in the Plasma Market
• The Red Blood Cell Collection Opportunity
• Robots in Blood Banking
• Blood Banks Switching from Manual to Automated Cooler Validation
• Automated Systems in Cancer
• Automated Blood Processing Systems in Open Heart Surgeries
• Cerus’ INTERCEPT Blood System Set to See Wider Adoption
• Pooling: Economical HIV Testing
• Ballooning Global Geriatric Populace to Drive Demand for Blood Products
• Improving Healthcare Expenditure to Foster Growth of Blood Banking Sector

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

• Total Companies Profiled: 209

For more information about this report visit https://www.researchandmarkets.com/r/bqwpaq

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900